印度證交會呼籲推動衍生產品市場結構性改革
據英國《金融時報》報道,印度證券交易委員會(SEBI)主席Tuhin Kanta Pandey宣布,當局正計劃推動衍生品市場的結構性改革,此前已實施散戶限制措施,並因涉嫌操縱市場而暫時禁止美國量化交易與投資管理公司簡街資本(Jane Street)在該市場交易。
簡街資本以6月中旬與恆地(00012.HK)簽約租用後者旗下中環新海濱旗艦項目第一期六層樓面,面積合共逾22.3萬平方呎,創中環核心商業區數十年來最大宗單一辦公室租賃紀錄而聞名。
Pandey指出,為保護散戶投資者,監管機構將致力遏止市場不當行為,雖然目前相關交易量已有所下降,但仍未達到理想水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.